Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT5 | Q11128 | 1/20 | 0.76 |
| ▸ | TGM2 | P21980 | 1/20 | 0.70 |
| ▸ | KRAS | P01116 | 4/20 | 0.66 |
| ▸ | NT5E | P21589 | 1/20 | 0.66 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.62 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.61 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.60 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.60 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.60 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.60 |
| ▸ | P2RY1 | P47900 | 3/20 | 0.57 |
| ▸ | SRC | P12931 | 1/20 | 0.57 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.57 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.57 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | HINT1 | P49773 | 1/20 | 0.57 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.57 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14293772 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL14293912 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL29456758 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL24496886 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL9438541 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL25319857 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL14268500 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL2229602 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL30646155 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 | |
| SCHEMBL29359526 | 1.00 | FUT5 (0.76) | FUT5TGM2KRASNT5EP2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12077788-B2 | Production of a mixture of neutral non-fucosylated oligosaccharides by a cell | INBIOSE N.V. (BE) | 2024-09-03 | — | — | US | claimed |
| US-20230416796-A1 | PRODUCTION OF GALACTOSYLATED DI- AND OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2023-12-28 | — | — | US | claimed |
| US-20230313253-A1 | PRODUCTION OF GLCNAC CONTAINING BIOPRODUCTS IN A CELL | INBIOSE N.V. (BE) | 2023-10-05 | — | — | US | claimed |
| US-20230287470-A1 | PRODUCTION OF OLIGOSACCHARIDE MIXTURES BY A CELL | INBIOSE N.V. (BE) | 2023-09-14 | — | — | US | claimed |
| US-20230265399-A1 | PRODUCTION OF A MIXTURE OF NEUTRAL NON-FUCOSYLATED OLIGOSACCHARIDES BY A CELL | INBIOSE N.V. (BE) | 2023-08-24 | — | — | US | claimed |
| EP-4192967-A1 | PRODUCTION OF A MIXTURE OF NEUTRAL FUCOSYLATED OLIGOSACCHARIDES BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | claimed |
| EP-4192944-A1 | PRODUCTION OF OLIGOSACCHARIDE MIXTURES BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | claimed |
| EP-4192969-A1 | PRODUCTION OF AN OLIGOSACCHARIDE MIXTURE BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | claimed |
| EP-4192973-A2 | PRODUCTION OF GALACTOSYLATED DI- AND OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | claimed |
| EP-4192971-A1 | PRODUCTION OF A MIXTURE OF NEUTRAL NON-FUCOSYLATED OLIGOSACCHARIDES BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | claimed |
| EP-4192972-A1 | PRODUCTION OF GLCNAC CONTAINING BIOPRODUCTS IN A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | claimed |
| EP-4192974-A1 | PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | claimed |
| WO-2022034069-A1 | PRODUCTION OF A MIXTURE OF NEUTRAL FUCOSYLATED OLIGOSACCHARIDES BY A CELL | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | claimed |
| WO-2022034075-A1 | PRODUCTION OF GLCNAC CONTAINING BIOPRODUCTS IN A CELL | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | claimed |
| WO-2022034076-A2 | PRODUCTION OF GALACTOSYLATED DI- AND OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | claimed |
| US-20260139285-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | INBIOSE N V (BE) | 2026-05-21 | — | — | US | disclosed |
| EP-4731778-A2 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2026-04-29 | — | — | EP | disclosed |
| WO-2022034069-A1 | PRODUCTION OF A MIXTURE OF NEUTRAL FUCOSYLATED OLIGOSACCHARIDES BY A CELL | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | disclosed |
| WO-2022034077-A1 | PRODUCTION OF ALPHA-1,3 GLYCOSYLATED FORM OF FUC-A1,2-GAL-R | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | disclosed |
| WO-2022034076-A2 | PRODUCTION OF GALACTOSYLATED DI- AND OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139285-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | GALNT3, NANS, ENGASE | FUT5 10/4885TGM2 766/4885KRAS 4085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.